Trial Profile
Chemotherapy With or Without Preventive Anticoagulation for Metastatic Cancer of the Pancreas
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Apr 2022
Price :
$35
*
At a glance
- Drugs Dalteparin sodium (Primary) ; Capecitabine; Gemcitabine
- Indications Pancreatic cancer; Thromboembolism
- Focus Biomarker; Therapeutic Use
- Acronyms GERCOR PAM07
- 02 Apr 2022 Status changed from discontinued to completed.
- 19 May 2008 New trial record.